• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

67.6800 AUD 0.1500 0.22%

As of 02:11:03 ET on 04/17/2014.

Snapshot for CSL Ltd (CSL)

Open: 67.9900 Day's Range: 67.4600 - 68.0200 Volume: 958,925
Previous Close: 67.5300 52wk Range: 56.1500 - 72.8200 1-Yr Rtn: +14.01%

Stock Chart for CSL

No chart data available.
  • CSL:AU 67.6800
  • 1D
  • 1M
  • 1Y
67.5300
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 25.0807
Estimated P/E(06/2014) 22.7392
Relative P/E vs. AS51 1.2855
Earnings Per Share (USD) (ttm) 2.5223
Est. EPS (USD) (06/2014) 2.7820
Est. PEG Ratio 1.8076
Market Cap (M AUD) 32,531.96
Shares Outstanding (M) 480.67
30 Day Average Volume 1,205,358
Price/Book (mrq) 9.3057
Price/Sale (ttm) 6.1472
Dividend Indicated Gross Yield 1.71%
Cash Dividend (AUD) 0.5888
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 16.93%
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerGregory Boss "Greg"Exec VP:Legal/Gen Cnsl
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil